Mizuho sees biopharma funding rise 56% in September on public deals

Go back to Mizuho sees biopharma funding rise 56% in September on public deals
CHARLES RIVER LABORATORIE (NYSE: CRL) Delayed: 344.87 +29.42 (9.33%)
Previous Close $315.45    52 Week High $89.18 
Open $313.83    52 Week Low $65.70 
Day High $348.95    P/E 160.40 
Day Low $313.83    EPS $2.15 
Volume 2,745,186       

Danaher Corp. (NYSE: DHR) Delayed: 233.86 +9.62 (4.29%)
Previous Close $224.24    52 Week High $102.79 
Open $217.56    52 Week Low $75.71 
Day High $234.40    P/E 61.54 
Day Low $217.55    EPS $3.80 
Volume 8,899,659       

Techne Corp (NASDAQ: TECH) Delayed: 72.64 +0.06 (0.08%)
Previous Close $72.58    52 Week High $117.42 
Open $72.54    52 Week Low $79.95 
Day High $72.65    P/E 23.51 
Day Low $72.50    EPS $3.09 
Volume 3,497,692       

Thermo Fisher Scientific (NYSE: TMO) Delayed: 694.02 +6.65 (0.97%)
Previous Close $687.37    52 Week High $160.68 
Open $665.00    52 Week Low $119.75 
Day High $705.79    P/E 198.29 
Day Low $661.30    EPS $3.50 
Volume 4,049,846